[go: up one dir, main page]

YU46547B - 1,4-dihidropiridini i postupak za njihovo dobijanje - Google Patents

1,4-dihidropiridini i postupak za njihovo dobijanje

Info

Publication number
YU46547B
YU46547B YU147088A YU147088A YU46547B YU 46547 B YU46547 B YU 46547B YU 147088 A YU147088 A YU 147088A YU 147088 A YU147088 A YU 147088A YU 46547 B YU46547 B YU 46547B
Authority
YU
Yugoslavia
Prior art keywords
dihydropyridines
obtaining
picolyl
thienylmethyl
fluorobenzyl
Prior art date
Application number
YU147088A
Other languages
English (en)
Other versions
YU147088A (en
Inventor
Torija C. Fernandez
Ramos J.A. Galiano
Original Assignee
La Boratorios Delagrange
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Boratorios Delagrange filed Critical La Boratorios Delagrange
Publication of YU147088A publication Critical patent/YU147088A/xx
Publication of YU46547B publication Critical patent/YU46547B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1,4-DIHIDROPIRIDINI I POSTUPAK ZA NJIHOVO DOBIJANJE, opšte formule: u kojoj R1 predstavlja C1-3alkil grupu pravog ili račvastog niza; R2 je metil grupa: R3 je 3-pikolil, 2-tienilmetil ili 4-fluorobenzil; i njihove farmaceutski prihvatljive adicione soli sa organskim ili mineralnim kiselinama. Prijava sadrži još dva nezavisna i 8 zavisnih patentnih zahteva.
YU147088A 1987-08-03 1988-07-29 1,4-dihidropiridini i postupak za njihovo dobijanje YU46547B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401799A EP0302980B1 (fr) 1987-08-03 1987-08-03 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments

Publications (2)

Publication Number Publication Date
YU147088A YU147088A (en) 1990-04-30
YU46547B true YU46547B (sh) 1993-11-16

Family

ID=8198243

Family Applications (1)

Application Number Title Priority Date Filing Date
YU147088A YU46547B (sh) 1987-08-03 1988-07-29 1,4-dihidropiridini i postupak za njihovo dobijanje

Country Status (34)

Country Link
US (1) US4952592A (sh)
EP (1) EP0302980B1 (sh)
JP (1) JPH0733383B2 (sh)
KR (1) KR960001724B1 (sh)
CN (1) CN1038587C (sh)
AT (1) ATE61588T1 (sh)
BE (1) BE1001055A4 (sh)
CA (2) CA1306261C (sh)
CH (1) CH675999A5 (sh)
CZ (1) CZ282077B6 (sh)
DD (1) DD282008A5 (sh)
DE (2) DE3768658D1 (sh)
DK (1) DK430288A (sh)
ES (1) ES2007543A6 (sh)
FI (1) FI91406C (sh)
GB (1) GB2208861B (sh)
GR (2) GR880100507A (sh)
HU (1) HU204523B (sh)
IE (1) IE60358B1 (sh)
IL (1) IL87321A (sh)
IN (1) IN167550B (sh)
IS (1) IS1549B (sh)
IT (1) IT1235013B (sh)
LU (1) LU87297A1 (sh)
MA (1) MA21344A1 (sh)
NO (1) NO170934C (sh)
NZ (1) NZ225661A (sh)
PH (1) PH25645A (sh)
PT (1) PT88173B (sh)
RU (1) RU2036922C1 (sh)
SK (1) SK541388A3 (sh)
TN (1) TNSN88081A1 (sh)
YU (1) YU46547B (sh)
ZA (1) ZA885684B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
EP0854721B1 (en) * 1995-08-02 2001-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists
DE60128683T2 (de) * 2000-04-11 2008-01-24 Sankyo Co., Ltd. Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
MX2007000979A (es) * 2004-07-26 2007-07-11 Cotherix Inc Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
ES8507495A1 (es) * 1984-03-27 1985-09-01 Inst Investigacion Desarrollo Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
JPH068294B2 (ja) * 1985-02-26 1994-02-02 富山化学工業株式会社 新規な１，４−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) * 1987-03-05 1989-08-21 Yamanouchi Pharmaceut Co Ltd ピリジン誘導体及び該化合物を含有する肝疾患治療剤

Also Published As

Publication number Publication date
MA21344A1 (fr) 1989-04-01
KR960001724B1 (ko) 1996-02-03
DE3825962A1 (de) 1989-02-16
TNSN88081A1 (fr) 1990-07-10
IE882364L (en) 1989-02-03
US4952592A (en) 1990-08-28
HUT54142A (en) 1991-01-28
IS1549B (is) 1994-06-08
DE3768658D1 (de) 1991-04-18
LU87297A1 (fr) 1989-02-02
NO170934B (no) 1992-09-21
SK278775B6 (sk) 1998-02-04
SK541388A3 (en) 1998-02-04
ATE61588T1 (de) 1991-03-15
FI91406C (fi) 1994-06-27
NZ225661A (en) 1990-08-28
IL87321A0 (en) 1989-01-31
HU204523B (en) 1992-01-28
RU2036922C1 (ru) 1995-06-09
IS3378A7 (is) 1989-02-04
PT88173A (pt) 1989-06-30
CZ541388A3 (en) 1997-01-15
IE60358B1 (en) 1994-06-29
JPH0733383B2 (ja) 1995-04-12
EP0302980B1 (fr) 1991-03-13
NO883406L (no) 1989-02-06
AU2033088A (en) 1989-02-09
CN1031531A (zh) 1989-03-08
DK430288D0 (da) 1988-08-02
PT88173B (pt) 1995-03-01
PH25645A (en) 1991-08-21
FI883603A0 (fi) 1988-08-01
IT1235013B (it) 1992-06-16
FI883603A (fi) 1989-02-04
JPH01294675A (ja) 1989-11-28
FI91406B (fi) 1994-03-15
GR3001984T3 (en) 1992-11-23
CZ282077B6 (cs) 1997-05-14
YU147088A (en) 1990-04-30
KR890003743A (ko) 1989-04-17
CA1306261C (fr) 1992-08-11
IT8848259A0 (it) 1988-08-02
BE1001055A4 (fr) 1989-06-20
CN1038587C (zh) 1998-06-03
AU606441B2 (en) 1991-02-07
CH675999A5 (en) 1990-11-30
NO170934C (no) 1992-12-30
ES2007543A6 (es) 1989-06-16
DK430288A (da) 1989-02-03
NO883406D0 (no) 1988-08-01
GR880100507A (el) 1989-05-25
IL87321A (en) 1993-04-04
GB8818356D0 (en) 1988-09-07
IN167550B (sh) 1990-11-10
DD282008A5 (de) 1990-08-29
ZA885684B (en) 1989-04-26
CA1306262C (fr) 1992-08-11
EP0302980A1 (fr) 1989-02-15
GB2208861A (en) 1989-04-19
GB2208861B (en) 1991-07-17

Similar Documents

Publication Publication Date Title
YU46547B (sh) 1,4-dihidropiridini i postupak za njihovo dobijanje
RS49531B (sr) Estrogen agonisti/antagonisti
FI855117A0 (fi) Segmenttipolyestereitä ja niiden kaltaisia yhdisteitä käytettäviksi lianirrotusaineina pesuainekoostumuksissa
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
DE69032981D1 (de) N-Heteroarylamidederivate als Inhibitoren von Acyl-Coenzym A: Cholesterol-Acyl-Transferase
ATE26120T1 (de) Substituierte acyl-derivate von 1,2,3,4tetrahydro-6,7-dimethoxy-3-isoquinolincarbons|ure.
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
ATE44954T1 (de) Carbostyrilderivat und verfahren zu seiner herstellung.
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
YU47554B (sh) RACEMSKI I OPTIČKI AKTIVNI DERIVATI PIRIDO (1,2-a) PIRAZINA I NJIHOVI INTERMEDIJERI
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
FI854445A0 (fi) Kinolonkarboxylsyraderivat.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ES470787A1 (es) Procedimiento para preparar derivados de benzoquinolicina
YU46483B (sh) Postupak za dobijanje kondenzovanih derivata pirimidina
BG92000A (bg) Метод за получаване на соли на 2',3'-дидеоксиинозин монохидрат,2',3'-дидеокси-2',3'-дидехидротимидин моно- хидрат и 2',3'-дидеокси-2'-флуоринозин хемихидрат
FR2517305B1 (fr) Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
ATE58135T1 (de) 1,3-oxathianderivate.
IE38141B1 (en) New 3,4-dihydropyridones their production and their medicinal use
KR890012951A (ko) 인단옥시아세트산 유도체 및 그의 제조방법
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
DK424888A (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
FR2426685A2 (fr) Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension
FI886046A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2-aminotetrahydroisokinoliinijohdannaisten valmistamiseksi